Insulet (Nasdaq:PODD) announced today that it debuted at the Consumer Electronics Show (CES) 2026 in Las Vegas.

Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.

Withings announced today that it partnered with Abbott (NYSE:ABT) to offer over-the-counter continuous glucose monitor (CGM) ...

Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).

As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...

Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care to integrate (AID) data.

Left, the Dexcom G7. Right, the Abbott FreeStyle Libre 2. Both expect to benefit from the latest Medicare win. [Images from Dexcom and Abbott] The Centers for Medicare & Medicaid Services today ...

The Insulet Omnipod 5 [Photo courtesy of Insulet] Insulet (Nasdaq:PODD) today announced a duo of updates related to its Omnipod 5 system that includes a significant integration development. Acton, ...

Oura and Stelo alongside the mobile app. [Image courtesy of Dexcom/Oura] As one of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

Left: the Abbott FreeStyle Libre 3 CGM. Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing ...

The Omnipod 5 with the Dexcom G7 CGM. [Image courtesy of Insulet] When it comes to the diabetes tech market, the Insulet (Nasdaq:PODD) Omnipod 5 automated insulin delivery system is nothing new.